Clinical Cardiology and Cardiovascular Disease

Mingguo Xu has completed his PhD at the age of 28 years from Sun Yat-Sen  University and postdoctoral studies from The Johns Hopkins Hospital. He is the director of pediatric department in ShenZhen Children’s Hospital. He is talented in pediatric cardiology, including interventional therapy of congenital heart disease and the basic research of Kawasaki disease. He has published more than 11 papers in reputed journals.

      Ventricular septal defect (VSD) is a common congenital heart disease in children. There are two methods to treat VSD in China, surgical operations and interventional operations using occluders produced in China. In our department, we have treated  1500 cases using occluders produced in China  from 2005 to 2017. The technique successful rate is higher than 99.8ï¼…. The rate of complications is less than 1ï¼…. The complications include heart block, occluder transposition,  femoral arteriovenous fistula and thrombosis in femoral artery and vein. We followed up these cases after the operation, which showed that the long-term effects are definite.  There is no case to be death because of the procedure. We concluded that children with VSD can be cured with interventional therapy using occluders produced in China with satisfactory results.